EUVIMEDEUVIMED entdecken
Open Access

Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies

Paras S Minhas iD, Jeffrey R Jones iD, Amira Latif-Hernandez, Yuki Sugiura iD, Aarooran S Durairaj iD, Qian Wang iD, Siddhita D Mhatre iD, Takeshi Uenaka iD, Joshua Crapser iD, Travis Conley iD, Hannah Ennerfelt iD, Yoo Jin Jung iD und 21 weitere

Science · 23.08.2024 · 385 (6711)

DOI: 10.1126/science.abm6131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 23.08.2024. Verfasst von Paras S Minhas und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Astrocytes, Glucose. Die Arbeit wurde bisher 247-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Impaired cerebral glucose metabolism is a pathologic feature of Alzheimer’s disease (AD), with recent proteomic studies highlighting disrupted glial metabolism in AD. We report that inhibition of indoleamine-2,3-dioxygenase 1 (IDO1), which metabolizes tryptophan to kynurenine (KYN), rescues hippocampal memory function in mouse preclinical models of AD by restoring astrocyte metabolism. Activation of astrocytic IDO1 by amyloid β and tau oligomers increases KYN and suppresses glycolysis in an aryl hydrocarbon receptor–dependent manner. In amyloid and tau models, IDO1 inhibition improves hippocampal glucose metabolism and rescues hippocampal long-term potentiation in a monocarboxylate transporter–dependent manner. In astrocytic and neuronal cocultures from AD subjects, IDO1 inhibition improved astrocytic production of lactate and uptake by neurons. Thus, IDO1 inhibitors presently developed for cancer might be repurposed for treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesAstrocytesGlucoseGlycolysisHippocampusIndoleamine-Pyrrole 2,3,-DioxygenaseKynurenineNeuronsAnimalsHumansMaleMiceCognitionDisease Models, AnimalLactic AcidLong-Term PotentiationMemoryMonocarboxylic Acid TransportersReceptors, Aryl Hydrocarbontau ProteinsTryptophan

Substanzen

Amyloid beta-PeptidesGlucoseIDO1 protein, humanIndoleamine-Pyrrole 2,3,-DioxygenaseKynurenineLactic AcidMonocarboxylic Acid TransportersReceptors, Aryl Hydrocarbontau ProteinsTryptophan

Autor:innen und Institutionen

  • Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA 94305, USA.
  • Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
  • Central Institute for Experimental Medicine and Life Science, Keio University, 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki 210-0821, Japan.
  • WPI-Bio2Q Research Center, Keio University, 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki 210-0821 Japan.
  • Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.

ORCID-Profile: Paras S Minhas, Jeffrey R Jones, Yuki Sugiura, Aarooran S Durairaj, Qian Wang, Siddhita D Mhatre, Takeshi Uenaka, Joshua Crapser, Travis Conley, Hannah Ennerfelt, Yoo Jin Jung, Praveena Prasad, Brenita C Jenkins, Yeonglong Albert Ay, Ryan Goodman, Kelly Heard, Austin Kang, Edward N Wilson, Tao Yang, Erik M Ullian, Geidy E Serrano, Thomas G Beach, Marius Wernig, Joshua D Rabinowitz, Makoto Suematsu, Frank M Longo, Melanie R McReynolds, Fred H Gage, Katrin I Andreasson

Förderung

  • NIGMS NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Minhas, P. S., Jones, J. R., Latif-Hernandez, A., Sugiura, Y., Durairaj, A. S., Wang, Q., Mhatre, S. D., Uenaka, T., Crapser, J., Conley, T., Ennerfelt, H., Jung, Y. J., Liu, L., Prasad, P., Jenkins, B. C., Ay, Y. A., Matrongolo, M., Goodman, R., Newmeyer, T., …, & Andreasson, K. I. (2024). Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies. Science, 385(6711). https://doi.org/10.1126/science.abm6131

Vancouver

Minhas PS, Jones JR, Latif-Hernandez A, Sugiura Y, Durairaj AS, Wang Q, et al. Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies. Science. 2024;385(6711). doi:10.1126/science.abm6131

BibTeX
@article{Minhas2024,
  author = {Minhas, Paras S and Jones, Jeffrey R and Latif-Hernandez, Amira and Sugiura, Yuki and Durairaj, Aarooran S and Wang, Qian and Mhatre, Siddhita D and Uenaka, Takeshi and Crapser, Joshua and Conley, Travis and Ennerfelt, Hannah and Jung, Yoo Jin and Liu, Ling and Prasad, Praveena and Jenkins, Brenita C and Ay, Yeonglong Albert and Matrongolo, Matthew and Goodman, Ryan and Newmeyer, Traci and Heard, Kelly and Kang, Austin and Wilson, Edward N and Yang, Tao and Ullian, Erik M and Serrano, Geidy E and Beach, Thomas G and Wernig, Marius and Rabinowitz, Joshua D and Suematsu, Makoto and Longo, Frank M and McReynolds, Melanie R and Gage, Fred H and Andreasson, Katrin I},
  title = {Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies},
  journal = {Science},
  year = {2024},
  volume = {385},
  number = {6711},
  doi = {10.1126/science.abm6131}
}
Kostenlos starten →